A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Normal adult men and women have been infused with epinephrine, 6 mug per minute, during lipolytic blockade with nicotinic acid, beta-adrenergic blockade with propranolol and Butoxamine, and alpha-adrenergic blockade with phentolamine. Epinephrine infusion was associated with low serum levels of immunoreactive insulin (IRI) except when phentolamine was given simultaneously. These findings are compatible with an alpha receptor mechanism for the epinephrine inhibition of insulin release. Phentolamine had no blocking effects on the tachycardia and widened pulse pressure or lipolytic stimulation by epinephrine, whereas both propranolol and Butoxamine blocked lipolysis, tachycardia, and widened pulse pressure. These findings are consistent with an alpha receptor blocking action for phentolamine and beta receptor blocking action for propranolol and Butoxamine. Inhibition of lipolysis by nicotinic acid did not alter IRI or glucose responses to epinephrine. It is concluded that the lipolytic effect of epinephrine is unrelated to its effects on IRI release. Lipolytic blockade by nicotinic acid also did not change IRI or glucose in fasting subjects or their responses to a glucose infusion, 300 mg per minute. These observations appear to conflict with the Randle hypothesis (the glucose-fatty acid cycle) and raise some doubt as to whether plasma FFA concentrations are direct determinants of glucose or IRI concentrations in normal man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
A STUDY OF THE ADRENOTROPIC RECEPTORS
Ahlquist, R. P. (1948) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1948.153.3.586 · Cited by 2,893
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,199
Titration of free fatty acids of plasma: a study of current methods and a new modification
Trout, D. L., Estes, E. H., & Friedberg, S. J. (1960) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39062-3 · Cited by 1,013
The effect of epinephrine on immunoreactive insulin levels in man.
Porte, D., Graber, A. L., Kuzuya, T., & Williams, R. H. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105335 · Cited by 541
Self-citationRegulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro
Coore, H., & Randle, P. (1964) · Biochemical Journal · doi:10.1042/bj0930066 · Cited by 540
The photometric microdetermination of blood glucose with glucose oxidase.
Saifer, A., & Gerstenfeld, S. (1958) · PubMed · Cited by 511
Inhibition of Insulin Release by Norepinephrine in Man
Porte, D., & Williams, R. H. (1966) · Science · doi:10.1126/science.152.3726.1248 · Cited by 238
Self-citationEffect of Adrenergic Blocking Agents on Fatty Acid Mobilization during Fasting.
GOODMAN, H. M., & Knobil, E. (1959) · Experimental Biology and Medicine · doi:10.3181/00379727-102-25293 · Cited by 123
Effects of adrenergic blocking agents on plasma free fatty acid concentrations
McElroy, W. T., & Spitzer, J. J. (1961) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1961.200.2.318 · Cited by 104
Cited by
Items 201–300 of 399
Clark, M. G., Patten, G. S., Filsell, O. H., & Rattigan, S. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)80664-4 · Cited by 21
Astesano, A., Régnauld, K., Ferrand, N., Gingras, D., Bendayan, M., Rosselin, G., & Emami, S. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700303 · Cited by 18
“cholamine (Porte 1967), glucose-dependent insulino-”
BackgroundProlonged insulin resistance following insulin-induced hypoglycaemia
Clore, J. N., Brennan, J. R., Gebhart, S. S. P., Newsome, H. H., Nestler, J. E., & Blackard, W. G. (1987) · Diabetologia · doi:10.1007/bf00274793 · Cited by 18
METABOLIC EFFECTS OF AUTONOMIC BLOCKADE
Pinter, E. J., PATTEE, C. J., Peterfy, G., & Cleghorn, J. M. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92093-4 · Cited by 16
Regulation of Carbohydrate Metabolism by Cyclic Nucleotides
Exton, J. H. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68393-0_1 · Cited by 17
Schafers, R., Elliott, H. L., Howie, C., & Reid, J. L. (1992) · PubMed Central · Cited by 15
Das, V. A., Robinson, R., & Paulose, C. S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9142-6 · Cited by 22
Epinephrine modifications of insulin release and of 86Rb+ or 45Ca2+ fluxes in rat islets
Tamagawa, T., & Henquin, J. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.244.3.e245 · Cited by 15
Mathé, A. A. (1971) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(71)90048-1 · Cited by 15
Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dog.
Robertson, R. P., & Guest, R. J. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109205 · Cited by 15
Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.
Gibbons, D. O., Lant, A. F., ASHFORD, A., Collins, R. F., & Pinder, S. (1976) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1976.tb00586.x · Cited by 15
Falkmer, S. E., Boquist, L., Foà, P. P., Grillo, T., Baxter‐Grillo, D. L., Sodoyez, J. C., Sodoyez‐Goffaux, F., & Whitty, A. J. (1969) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1969.tb04500.x · Cited by 15
Alpha 2-adrenergic modulation of pancreatic glucagon secretion in rats
Saito, M. K., Saitoh, T., & Inoue, S. (1992) · Physiology & Behavior · doi:10.1016/0031-9384(92)90303-j · Cited by 14
Adrenergic changes due to pertussis: Insulin, glucose and free fatty acids
TABACHNICK, I. I. A., & Gulbenkian, A. R. (1969) · European Journal of Pharmacology · doi:10.1016/0014-2999(69)90009-0 · Cited by 14
INSULIN, ADENYL CYCLATE, IONS, AND THE HEART
KONES, R. J. (1974) · Transactions of the New York Academy of Sciences · doi:10.1111/j.2164-0947.1974.tb01608.x · Cited by 15
Henquin, J. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154821 · Cited by 16
Meechan, J. G., & Welbury, R. R. (1992) · PubMed · Cited by 13
INHIBITION OP INSULIN RELEASE BY DIAZOXIDE AND ITS RELATION TO CATECHOLAMINE EFFECTS IN MAN
Porte, D. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb19052.x · Cited by 13
Self-citationGoodman, C., & Goetz, F. C. (1970) · Metabolism · doi:10.1016/0026-0495(70)90034-x · Cited by 12
Insulin and glucagon secretion in swimming mice: effects of adrenalectomy and chemical sympathectomy
Karlsson, S., & Åhrén, B. (1991) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(91)90112-g · Cited by 12
Åhrén, B., Järhult, J., & Lundquist, I. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07073.x · Cited by 14
The effect of adrenergic blockade upon shock-induced lacticacidosis in sheep
Irving, M. H., Varga, D., Gillett, D. J., & Halmagyi, D. F. J. (1968) · British journal of surgery · doi:10.1002/bjs.1800551017 · Cited by 12
Effect of propranolol on some adrenaline- and insulin-induced metabolic changes in man
MASSARA, F., Camanni, F., & Molinatti, G. M. (1975) · Acta Diabetologica · doi:10.1007/bf02581111 · Cited by 12
Innervation of endocrine tissues
Unsicker, K. (1984) · Springer eBooks · doi:10.1007/978-1-4613-3861-1_28 · Cited by 13
Effect of intravenous glucose infusion on plasma insulin removal rate
Olefsky, J. M., Batchelder, T., Colome, S. D., & Reaven, G. M. (1974) · Metabolism · doi:10.1016/0026-0495(74)90082-1 · Cited by 14
Effect of hyperammonemia on insulin-mediated glucose uptake in rats
Schlienger, J.-L., & Imler, M. (1978) · Metabolism · doi:10.1016/0026-0495(78)90163-4 · Cited by 11
Ahr�n, B., & Lundquist, I. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00582705 · Cited by 11
“In addition, noradrenaline and adrenaline have been shown to have the capabili ty to inhibit insulin secretion through their c~-adrenoceptor st imulat0ry proper ty [20, 21] whereas/%adrenoceptor st imulation initiates insulin secretion [16, 17, 19] suggesting a dual effect of catecholamines on the insulin secreting me…”
BackgroundIn vivo insulin secretion: Prostaglandin and adrenergic interrelationships
Robertson, R. P. (1974) · Prostaglandins · doi:10.1016/s0090-6980(74)80060-2 · Cited by 11
Possible Mechanism of Hypoglycemia Following Removal of Pheochromocytoma
Sagalowsky, A. I., & Donohue, J. P. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55479-8 · Cited by 11
Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide
Anderson, J. H., Byrd, G. W., & Blackard, W. G. (1971) · Metabolism · doi:10.1016/0026-0495(71)90025-4 · Cited by 11
Metabolic and cardiovascular effects of adrenaline and alprenolol (Aptin®) in human subjects
Kral, J. G., �blad, B., Bj�rntorp, P., Ek, L., & Johnsson, G. (1969) · European Journal of Clinical Pharmacology · doi:10.1007/bf00404185 · Cited by 11
Pontén, J., Biber, B., Henriksson, B. ‐., Hjalmarson, Å. C., & Lundberg, D. (1982) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1982.tb01818.x · Cited by 11
Neri, V., Bartorelli, A., & Faglia, G. (1969) · Acta Diabetologica · doi:10.1007/bf01548087 · Cited by 12
Chap, Z., Ishida, T., Chou, J., Michael, L., Hartley, C. J., Entman, M. L., & Field, J. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112441 · Cited by 10
The Effects of PACAP on Insulin Secretion and Glucose Disposal Are Altered by Adrenalectomy in Mice
Åhrén, B., & Filipsson, K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06973.x · Cited by 11
Anomalous Glucose and Insulin Responses in Patients With Insulinoma: Caveats for Diagnosis
Dons, R. F., Hodge, J., Ginsberg, B. H., Brennan, M. F., Cryer, P. E., Kourides, I. A., & Gorden, P. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.10.1861 · Cited by 10
Glucose metabolism and insulin activity during cardiac surgery.
Mescheryakov, A. V., Козлов, И. А., Dementyeva, I., Lakhter, M. A., Ermolyn, A. J., & Galyibin, A. A. (1989) · Journal of Cardiothoracic Anesthesia · doi:10.1016/0888-6296(89)90149-x · Cited by 10
ANTI‐INFLAMMATORY ACTION OF GLUCAGON IN RATS
Leme, J. G., Morato, M., & SOUZA, M. Z. A. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07611.x · Cited by 10
Impaired insulin secretion in human diabetes mellitus. I. The effect of alpha-adrenergic inhibition
Giugliano, D., Cerciello, T., Giannetti, G., Ceriello, A., Giunta, R. E., & Frascolla, N. (1982) · Pharmacological Research Communications · doi:10.1016/s0031-6989(82)80031-3 · Cited by 10
Suppression of portal venous insulin concentration by epinephrine in the conscious monkey
Miller, R. E., & Soeldner, J. S. (1969) · Diabetologia · doi:10.1007/bf01213676 · Cited by 10
“This concNsion is supported by the fact tha t POt~TE found no rise in peripheral sugar or IR I during an hour-long infusion of phentolamine in a single patient [7].”
BackgroundResultInfluentialGlucose Intolerance in Nonischemic Cardiac Disease
Ettinger, P. O., Oldewurtel, H. A., Dzindzio, B. S., Sethi, V., & Regan, T. J. (1971) · Circulation · doi:10.1161/01.cir.43.6.809 · Cited by 12
Antidepressant Drugs and Excessive Weight Gain
Winston, F., & McCann, M. L. (1972) · The British Journal of Psychiatry · doi:10.1192/bjp.120.559.693 · Cited by 10
Adrenergic beta blockade and changes in plasma potassium following epinephrine administration
Grassi, A. O., de Lew, M. F., Cingolani, H. E., & Blesa, E. S. (1971) · European Journal of Pharmacology · doi:10.1016/0014-2999(71)90175-0 · Cited by 9
Hermansen, K., & Hyttel, I. (1971) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1971.tb00586.x · Cited by 11
Potentiators and Inhibitors of Insulin Secretion
Åhrén, B. (1999) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(08)60093-4 · Cited by 10
Arnold, A. (1980) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-67505-8_2 · Cited by 12
The effects of epinephrine on islet hormone secretion in the dog
Ahrén, B., Veith, R. C., & Taborsky, G. J. (1988) · International Journal of Pancreatology · doi:10.1007/bf02788471 · Cited by 9
Christopher, M., Sleeman, M. W., ALFORD, F. P., & Best, J. D. (1992) · Diabetologia · doi:10.1007/bf02342433 · Cited by 9
Müeller, I., Rao, P. S., Fletcher, J. W., Evans, R., HERTELENDY, F., Stickley, L., & Walter, K. E. (1979) · Clinical Cardiology · doi:10.1002/clc.4960020602 · Cited by 9
Disordered Glucose and Insulin Metabolism in Patients With Insulinoma
Shen, S.-W. (1975) · Archives of Internal Medicine · doi:10.1001/archinte.1975.00330050042006 · Cited by 9
Kulshreshtha, B., Thonangi, R., & Bhardwaj, M. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.129120 · Cited by 8
“Stimulation of b‐adrenoreceptors by catecholamines causes enhanced glycogenolysis and gluconeogenesis by the liver resulting in transient increase in glucose production.[8] Direct stimulation by noradrenaline on α‐adrenoreceptors of pancreas, causes inhibition of insulin release whereas stimulation of b‐adrenoreceptor…”
BackgroundDonnelly, R., & Morris, A. D. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04283.x · Cited by 8
Al‐Jibouri, L. M., Furman, B. L., & Parratt, J. R. (1980) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1980.tb14559.x · Cited by 8
The metabolic, circulatory, and bronchomotor responses of asthmatic children to epinephrine infusion
Lecks, H. I., Wood, D. W., & Donsky, G. (1969) · Journal of Allergy · doi:10.1016/0021-8707(69)90031-8 · Cited by 9
Antilipolytic effect of propranolol in the dog
Grassi, A., Lew, M., & Cingolani, H. (1969) · Life Sciences · doi:10.1016/0024-3205(69)90053-8 · Cited by 8
Metabolic response to simultaneous infusion of epinephrine and Propranolol in obese adolescents
Parra, A., & Schultz, R. B. (1969) · Metabolism · doi:10.1016/0026-0495(69)90143-7 · Cited by 8
Plasma corticosteroids, free fatty acids, insulin and glucose in maternal blood during delivery
Nieschlag, E., Wombacher, H., Kremer, G. J., & Martin, K. (1970) · Journal of Molecular Medicine · doi:10.1007/bf01497215 · Cited by 8
Foà, P. P. (2007) · Springer eBooks · doi:10.1007/bfb0107253 · Cited by 9
Li, L., Yang, J., Liu, B., Zou, Y., Sun, M., Li, Z., Yang, R., Xu, X., Zou, L., Li, G., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110803 · Cited by 8
Pheochromocytoma-Induced Hyperglycemia Leading To Misdiagnosis Of Type 1 Diabetes Mellitus
Bole, D., & Simon, B. F. (2016) · AACE Clinical Case Reports · doi:10.4158/ep161210.cr · Cited by 9
Shahim, B., Faxén, U. L., Stern, R., & Freyschuss, A. (2019) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytz177 · Cited by 7
“Direct stimulation of the pancreatic a-adrenoreceptors by norepinephrine causes inhibition of insulin release, whereas stimulation of b-adrenoreceptors by epinephrine results in insulin release, especially in conditions where glycogen stores are depleted.(14) In most situations, the areceptor-mediated insulin inhibiti…”
BackgroundDiani, A. R., Peterson, T., & Gilchrist, B. J. (1983) · Journal of Neural Transmission · doi:10.1007/bf01243280 · Cited by 7
Sweetness and Eating Disorders
Rodin, J., & Reed, D. R. (1987) · ILSI human nutrition reviews · doi:10.1007/978-1-4471-1429-1_13 · Cited by 7
Physiologie und Biochemie der endokrinen Regulationen und Korrelationen
Kühnau, J. (1971) · Handbuch der allgemeinen Pathologie · doi:10.1007/978-3-642-65168-7_2 · Cited by 10
Observations on the effect of a ganglion blocking agent on responses to intravenous glucose infusion
Burr, I. M., Hudson, W., Page, D., & TAFT, H. P. (1970) · Diabetologia · doi:10.1007/bf01211885 · Cited by 7
“This is consistent with the observation that adrenaline [24] and noradrenaline inhibit insulin release [33], an effect which is dependent on the integrity of pancreatic alpha-adrenergic receptors [32].”
BackgroundRizza, R. A., Haymond, M. W., & Gerich, J. E. (1982) · Metabolism · doi:10.1016/0026-0495(82)90053-1 · Cited by 8
Metabolic and hormonal effects of preferential beta1 and beta2-adrenoceptor stimulation in man
Tantucci, C., Santeusanio, F., Beschi, M., Castellano, M., Sorbini, C., & Grassi, V. (1988) · Journal of Endocrinological Investigation · doi:10.1007/bf03350152 · Cited by 7
PROSTAGLANDIN ADMINISTRATION FOR INDUCTION OF MID-TRIMESTER ABORTION IN COMPLICATED PREGNANCIES
Toppozada, M., Bygdeman, M., & Wiqvist, N. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92991-1 · Cited by 7
Chambers, J. W., GEORG, R. H., & Bass, A. D. (1972) · Life Sciences · doi:10.1016/0024-3205(72)90033-1 · Cited by 7
Hyperlactataemia during intravenous feeding in childhood
Aynsley-Green, A., Baum, J. D., Alberti, K. G. M. M., & Woods, H. F. (1974) · Archives of Disease in Childhood · doi:10.1136/adc.49.8.647 · Cited by 7
Renata, L., Larizza, D., Cammareri, V., & Francesca, S. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb02990.x · Cited by 7
Effects of Adrenergic Activators and Inhibitors on the Endocrine System
Potter, D. E. (1981) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-67584-3_4 · Cited by 7
Tsuchiya, H., Ushijima, K., Fujiwara, Y., Fujimura, A., & Koshimizu, T. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2011.11.011 · Cited by 6
“…and a1-adrenergic receptors in rat liver in an age-dependent manner (Liggett, 2009; Morgan et al., 1983), whereas insulin secretion is promoted by b2 agonists and inhibited by a2-receptor stimulation in rats and humans (Cherksey et al., 1983; Fyles et al., 1986; Porte, 1967; Porte et al., 1966).”
BackgroundSt-Pierre, D. H., Benso, A. S., Gramaglia, E., Prodam, F., Lucatello, B. G., Gigliardi, V. R., Olivetti, I., Tomelini, M., & Broglio, F. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346604 · Cited by 6
Bloom, S. R., & Edwards, A. V. (1985) · The Journal of Physiology · doi:10.1113/jphysiol.1985.sp015679 · Cited by 6
Park, S.-H., Kim, S., Lee, J.-R., Sharma, N., & Suh, H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.055 · Cited by 6
Case of reversible diabetes mellitus in the setting of benign pheochromocytoma
Cha, J., Khurram, M., Gellert, L. L., Epstein, P. N., Baregamian, N., & Hendrickson, C. D. (2018) · Journal of Clinical and Translational Endocrinology Case Reports · doi:10.1016/j.jecr.2018.07.003 · Cited by 6
Urinary metabolomic signatures in reticular oral lichen planus
Yang, X.-Y., Li, X., & Zhang, S. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04041 · Cited by 8
Lipson, M. J., Naimi, S., & PROGER, S. H. (1971) · Metabolism · doi:10.1016/0026-0495(71)90006-0 · Cited by 7
A study of insulin secretion in thoracic duct lymph of the dog.
Pepin, J., Singh, H., Pairent, F. W., Appert, H. E., & Howard, J. M. (1970) · PubMed · Cited by 6
Turtle, J. R. (1969) · Australasian Annals of Medicine · doi:10.1111/imj.1969.18.1.59 · Cited by 8
Integration of the Secretory Control Mechanisms for Insulin, Glucagon, and Growth Hormone
Blackard, W. G., & Andrews, S. S. (1974) · Current topics in experimental endocrinology · doi:10.1016/b978-0-12-153202-4.50011-x · Cited by 6
Induction of tyrosine aminotransferase by phentolamine
Govier, W. C., & Lovenberg, W. M. (1969) · Biochemical Pharmacology · doi:10.1016/0006-2952(69)90197-x · Cited by 6
Assessment of effects of β-blocking drugs on blood glucose levels and insulin hypoglycaemia in rats
Baird, J. R. C., & Carter, A. J. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90064-8 · Cited by 6
Lack of effect of somatostatin on epinephrine-stimulated glucose production in the dog
Stevenson, R. W., Steiner, K., Williams, P. E., & Cherrington, A. D. (1987) · Metabolism · doi:10.1016/0026-0495(87)90042-4 · Cited by 6
Epstein, S., Pimstone, B. L., Vinik, A. I., & McLAREN, H. (1975) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1975.tb01560.x · Cited by 6
Plasma Insulin Levels During Prolonged Exercise
Pruett, E. D. R. (1971) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-4609-8_16 · Cited by 9
Jadzinsky, M. N., Faerman, I., & Fox, D. (1973) · Acta Diabetologica · doi:10.1007/bf02590660 · Cited by 6
Niemeyer, H., & Ureta, T. (1972) · Elsevier eBooks · doi:10.1016/b978-0-12-272850-1.50015-5 · Cited by 6
Endocrine Disorders that Cause Diabetes
Jennings, R. E., & Hanley, N. A. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch20 · Cited by 5
Effects of Adrenergic Agonists and Antagonists on Glycogenolysis in Isolated Perfused Rat Liver
Tohkin, M., & Matsubara, T. (1987) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.45.233 · Cited by 5
Overview of Glucose Metabolism
Holt, R. I. G. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch6 · Cited by 6
An in vitro system for studying insulin release: effects of glucose and glucose‐6‐phosphate
Davis, B., & Lazarus, N. R. (1977) · The Journal of Physiology · doi:10.1113/jphysiol.1977.sp012000 · Cited by 5
SYMPATHETIC OVERACTIVITY AND CORONARY RISK IN HYPERTENSION
Amerena, J. V., & Julius, S. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00882.x · Cited by 5
Oshida, Y., OHSAWA, I., Sato, J., & Sato, Y. (1993) · Endocrine Journal · doi:10.1507/endocrj.40.99 · Cited by 6
Gordon, R. D., Bachmann, A. W., Ballantine, D. M., & Thompson, R. E. (1991) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1991.tb01448.x · Cited by 5
The Pathogenesis of Diabetes Mellitus
Clarke, B. F. (1970) · Scottish Medical Journal · doi:10.1177/003693307001500906 · Cited by 5
“Beta adrenergic receptors probably participate in the physiological stimulation of insulin release acting via the adenyl cyclase system (Porte, 1967b) with which the receptors are probably closely associated (Robison et 01., 1967), and stimulation augments the intracellular accumulation of cyclic…”
Alterazioni lipidemiche nel diabete mellito
Avogaro, P., Capri, C., Cazzolato, G., & Pais, M. (1972) · Acta Diabetologica · doi:10.1007/bf01564570 · Cited by 7
Rousseau-Migneron, S., Nadeau, A., & Tancrède, G. (1980) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y80-047 · Cited by 4
Endocrine Regulation of Neonatal Hypoxia: Role of Glucose, Oxygen, and Epinephrine Supplementation
Anju, T. R., Nandhu, M. S., P, J. J., & Cs, P. (2011) · Fetal and Pediatric Pathology · doi:10.3109/15513815.2011.587498 · Cited by 5
“An increase in plasma epinephrine concentration causes insulin resistance [29, 30].”
Background
Metadata
- Authors
- Porte, D.
- Affiliations
- United States Department of Veterans Affairs (US)
- Corresponding author
- Porte, Daniel
- Venue
- Journal of Clinical Investigation
- Published
- 1967-01-01
- Volume
- 46
- Issue
- 1
- Pages
- 86-94
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC297023
- OpenAlex
- W2063562555
- Cited by
- 398
- References
- 20
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 2 · 2013: 1
- FWCI
- 65.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Washington
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- epinephrine, insulin secretion, alpha-adrenergic receptors, phentolamine, propranolol, butoxamine, nicotinic acid, lipolysis, glucose-fatty acid cycle, free fatty acids, tachycardia, pulse pressure, glucose infusion, immunoreactive insulin
- MeSH terms
- Blood Glucose, Blood Pressure, Epinephrine, Female, Humans, Insulin, Lipids, Male, Nicotinic Acids, Phentolamine, Propranolol, Sensory Receptor Cells, Sympatholytics, Tachycardia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.